Mortality studies in heart failure. the role of ACE inhibitors becomes more important
Hofman-Bang, C.; Rydén, L.; Ponikowski, P.
Lakartidningen 88(51-52): 4407-4409
1991
ISSN/ISBN: 0023-7205 PMID: 1774980 Document Number: 387593
Document emailed within 1 workday
Related Documents
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108Huang, J. 2006: The important role of angiotensin receptor blocker on treatment of chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 34(9): 773-774
Trindade, P.T.; Rouleau, J.L. 2001: Vasopeptidase inhibitors: potential role in the treatment of heart failure Heart Failure Monitor 2(1): 2-7
Ypenburg, C.; Verwey, H.F.; van der Wall, E.E. 2007: Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner Nederlands Tijdschrift Voor Geneeskunde 151(44): 2426-2428
McMurray, J.J. 1998: Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? European Heart Journal 19(Suppl): L15-L21
1994: ACE inhibitors and kidney failure in heart failure Giornale Italiano di Cardiologia 24(5): 645-648
Maldonado Martin, A.; Gil Extremera, B.; Rubio Luengo, M.A. 1995: Does the diuretic effect of calcium inhibitors play an important role in the hypertensive efficacy? Presse Medicale 24(14): 686-690
Jahrmärker, H. 1993: When must, when should, when can ACE inhibitors be administered in heart failure? Medizinische Klinik 88(8): 496-502
Held, P.; Swedberg, K. 1990: ACE inhibitors in the treatment of heart failure Nordisk Medicin 105(8-9): 217-218
Reid, J. 1993: Are ACE inhibitors equal in congestive heart failure? South African Medical Journal: 1-3
Komajda, M. 1999: ACE inhibitors in heart failure: the question of dose International Journal of Clinical Practice. Supplement 100: 12-14
Packer, M. 1995: Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 92(6): 1379-1382
Widimský, J.ří 2015: The new drug is much more effective than ACE inhibitors in chronic heart failure Vnitrni Lekarstvi 61(2): 129-133
Swedberg, K.; Skoglund, I. 2005: The use of beta blockaders in chronic heart failure shows how important the application of evidence based medicine really is Lakartidningen 102(8): 580
Zannad, F. 1992: Management of the treatment with converting enzyme inhibitors in chronic heart failure La Revue du Praticien 42(20): 2563-2567
Ikram, H.; Nicholls, M.G.; Fitzpatrick, M.A.; Crozier, I.G. 1986: ACE inhibitors or inotropic drugs after diuretics in heart failure--a personal critique Postgraduate Medical Journal 62(Suppl 1): 176-178
Guazzi, M.D.; Berti, M.; Dardani, M.; Muratori, E.; Guazzi, M. 1989: Two sides of the coin, or converting enzyme inhibitors in the therapy of heart failure Cardiologia 34(1): 15-18
Arslanagić, A.; Raljević, E. 1999: Converting enzyme inhibitors in acute myocardial infarct and heart failure Medicinski Arhiv 53(1): 29-31
Simko, F.; Riecanský, I. 1996: ACE-inhibitors in the treatment of chronic heart failure: pathophysiologic principles of protective effects Bratislavske Lekarske Listy 97(10): 583-586
Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906